BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19771361)

  • 1. Decavanadate interactions with actin: cysteine oxidation and vanadyl formation.
    Ramos S; Duarte RO; Moura JJ; Aureliano M
    Dalton Trans; 2009 Oct; (38):7985-94. PubMed ID: 19771361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances into vanadyl, vanadate and decavanadate interactions with actin.
    Ramos S; Moura JJ; Aureliano M
    Metallomics; 2012 Jan; 4(1):16-22. PubMed ID: 22012168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decavanadate interactions with actin: inhibition of G-actin polymerization and stabilization of decameric vanadate.
    Ramos S; Manuel M; Tiago T; Duarte R; Martins J; Gutiérrez-Merino C; Moura JJ; Aureliano M
    J Inorg Biochem; 2006 Nov; 100(11):1734-43. PubMed ID: 16890293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of oxidovanadium(IV) binding to actin.
    Ramos S; Almeida RM; Moura JJ; Aureliano M
    J Inorg Biochem; 2011 Jun; 105(6):777-83. PubMed ID: 21497575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin as a potential target for decavanadate.
    Ramos S; Moura JJ; Aureliano M
    J Inorg Biochem; 2010 Dec; 104(12):1234-9. PubMed ID: 20807665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decavanadate binding to a high affinity site near the myosin catalytic centre inhibits F-actin-stimulated myosin ATPase activity.
    Tiago T; Aureliano M; Gutiérrez-Merino C
    Biochemistry; 2004 May; 43(18):5551-61. PubMed ID: 15122921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An EXAFS Approach to the Study of Polyoxometalate-Protein Interactions: The Case of Decavanadate-Actin.
    Marques MPM; Gianolio D; Ramos S; Batista de Carvalho LAE; Aureliano M
    Inorg Chem; 2017 Sep; 56(18):10893-10903. PubMed ID: 28858484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decavanadate induces mitochondrial membrane depolarization and inhibits oxygen consumption.
    Soares SS; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2007 May; 101(5):789-96. PubMed ID: 17349695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP.
    Sciortino G; Aureliano M; Garribba E
    Inorg Chem; 2021 Jan; 60(1):334-344. PubMed ID: 33253559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decavanadate as a biochemical tool in the elucidation of muscle contraction regulation.
    Tiago T; Aureliano M; Moura JJ
    J Inorg Biochem; 2004 Nov; 98(11):1902-10. PubMed ID: 15522416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of hydroxyurea with oxovanadium(V) ions in acidic aqueous solution.
    Gabricević M; Besić E; Birus M; Zahl A; Eldik Rv
    J Inorg Biochem; 2006 Oct; 100(10):1606-13. PubMed ID: 16842853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition.
    Fraqueza G; Batista de Carvalho LA; Marques MP; Maia L; Ohlin CA; Casey WH; Aureliano M
    Dalton Trans; 2012 Nov; 41(41):12749-58. PubMed ID: 22968713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of ATP(adenosine triphosphate)-vanadyl complexes.
    Sakurai H; Goda T; Shimomura S; Yoshimura T
    Nucleic Acids Symp Ser; 1982; (11):253-6. PubMed ID: 6306604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities.
    Aureliano M; Crans DC
    J Inorg Biochem; 2009 Apr; 103(4):536-46. PubMed ID: 19110314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization.
    Soares SS; Henao F; Aureliano M; Gutiérrez-Merino C
    Chem Res Toxicol; 2008 Mar; 21(3):607-18. PubMed ID: 18251508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decavanadate inhibits catalysis by ribonuclease A.
    Messmore JM; Raines RT
    Arch Biochem Biophys; 2000 Sep; 381(1):25-30. PubMed ID: 11019816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of skeletal muscle S1-myosin ATPase by peroxynitrite.
    Tiago T; Simão S; Aureliano M; Martín-Romero FJ; Gutiérrez-Merino C
    Biochemistry; 2006 Mar; 45(11):3794-804. PubMed ID: 16533063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration.
    Soares SS; Martins H; Duarte RO; Moura JJ; Coucelo J; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2007 Jan; 101(1):80-8. PubMed ID: 17030392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxynitrite induces F-actin depolymerization and blockade of myosin ATPase stimulation.
    Tiago T; Ramos S; Aureliano M; Gutiérrez-Merino C
    Biochem Biophys Res Commun; 2006 Mar; 342(1):44-9. PubMed ID: 16480685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent perspectives into biochemistry of decavanadate.
    Aureliano M
    World J Biol Chem; 2011 Oct; 2(10):215-25. PubMed ID: 22031844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.